Primevax Immuno-Oncology has a total of 52 patents globally, out of which 10 have been granted. Of these 52 patents, more than 53% patents are active. The United States of America is where Primevax Immuno-Oncology has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States
Nura Bio has a total of 12 patents globally, out of which 1 have been granted. Of these 12 patents, more than 83% patents are active. The United States of America is where Nura Bio has filed the maximum number of patents, followed by Europe. Parallelly, United States of America
Kartos Therapeutics has a total of 35 patents globally, out of which 1 has been granted. Of these 35 patents, more than 85% patents are active. Taiwan is where Kartos Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D
Innate Biologics has a total of 12 patents globally, out of which no patent has been granted. Of these 12 patents, more than 83% patents are active. The United States of America and Hong Kong (S.A.R.) is where Innate Biologics has filed the maximum number of patents. Parallelly, United States
Imbria Pharmaceuticals has a total of 96 patents globally, out of which 14 have been granted. Of these 96 patents, more than 71% patents are active. The United States of America is where Imbria Pharmaceuticals has filed the maximum number of patents, followed by Europe and Israel. Parallelly, United States
Rome Therapeutics has a total of 8 patents globally. Of these 8 patents, all the patents are active. The United States of America is where Rome Therapeutics has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin
AgroSpheres has a total of 47 patents globally, out of which 2 have been granted. Of these 47 patents, more than 78% patents are active. Canada is where AgroSpheres has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.